Floatz logo

S-Ketamine

Depressive Disorder

Chinese PLA General HospitalPhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
76/ 100
Competitive Position
73/ 100

Competitive context

90 Active assets in the Depressive Disorder cohort.

Asset / SponsorPhaseRating
Opc-34712
Dr. Albert Kar-Kin Chung
Phase 4A
Saredutant
Sanofi
Phase 3BBB
Paroxetine
Brigham and Women's Hospital
Phase 4BBB
Cipralex
Poznan University of Medical Sciences
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
VA Office of Research and Development
Phase 4BBB

View all 50 →

Same molecule, other indications

S-Ketamine is also rated in:

depressive disorderDormant
A
Indicative ·
81 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
76 / 100
View asset →
EsketamineDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →